SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 263 filers reported holding SAGE THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 2.21 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $363,000 | -23.7% | 6,389 | +0.4% | 0.02% | -28.1% |
| Q1 2021 | $476,000 | -13.1% | 6,362 | +0.5% | 0.03% | -15.8% |
| Q4 2020 | $548,000 | +40.5% | 6,330 | -0.8% | 0.04% | +40.7% |
| Q3 2020 | $390,000 | -34.7% | 6,379 | +49.9% | 0.03% | -18.2% |
| Q3 2019 | $597,000 | -25.7% | 4,255 | -3.0% | 0.03% | -25.0% |
| Q2 2019 | $803,000 | +36.1% | 4,387 | +18.2% | 0.04% | +41.9% |
| Q1 2019 | $590,000 | +81.0% | 3,712 | +9.1% | 0.03% | +72.2% |
| Q4 2018 | $326,000 | -18.9% | 3,403 | +19.6% | 0.02% | +5.9% |
| Q3 2018 | $402,000 | – | 2,845 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Integral Health Asset Management, LLC | 311,000 | $10,294,000 | 2.68% |
| Palo Alto Investors LP | 851,719 | $28,192,000 | 2.18% |
| Boxer Capital, LLC | 1,094,000 | $36,211,000 | 1.86% |
| DAFNA Capital Management LLC | 180,306 | $5,968,000 | 1.56% |
| Deep Track Capital, LP | 675,000 | $22,343,000 | 1.43% |
| Bellevue Group AG | 3,052,404 | $101,034,000 | 1.17% |
| Ikarian Capital, LLC | 249,907 | $8,272,000 | 1.09% |
| Ikarian Capital, LLC | 250,000 | $8,275,000 | 1.09% |
| Artal Group S.A. | 750,000 | $24,825,000 | 1.04% |
| SECTOR GAMMA AS | 118,476 | $3,922,000 | 0.85% |